NASDAQ Golden Dragon China Index

Bilibili Q1 Report: AI Ad Revenue Surges 30%, Game Revenue Drops 12%

JD Industrial Development Signs Strategic Cooperation Agreement with Songmics to Build Overseas Warehouse Ecosystem

Wednesday Market Focus: US/EU/UK CPI Data and Central Bank Speeches, ZTO Express Reports Results

ECARX Holdings Reports Q1 2026 Financial Results: Revenue Down 22%, Announces Partnership with May Mobility

ECARX Partners with May Mobility to Develop Autonomous Ride-Hailing Fleet, Valued at $750 Million

Bilibili Q1 Daily Active Users Rise 8% to 115.2 Million

Li Auto Inc. spends approx. $12.0659 million to repurchase 1.4408 million shares

Bilibili Q1 Net Revenue Rises 7% to 7.47 Billion, Adjusted Net Profit Jumps 62% to 585 Million

Bilibili Q1 Adjusted EPS Hits 1.31 Yuan, Beating Estimates

KE Holdings Q1 FY2026 Earnings: Net Income Surges 46.7% to 1.26B RMB Despite 19% Revenue Decline

Alibaba's Qwen Large Model to Receive a Major Upgrade

Beike Q1 2026 Adjusted Net Profit RMB 1.611 Billion, Up 15.7%

HKEX Discloses Goldman Sachs Reduced Zai Lab Stake to 6.67%

JD.com Q1 Earnings: Revenue Up 4.9%, Net Profit Down 53% as New Business Segment Suffers Massive Losses

Profund Advisors LLC Reduces Stake in Alibaba

Nio China Charging Stations Exceed 5,000, Plans Infrastructure Expansion

Hesai Group Q1 Net Profit 18.3M RMB, Appointed Mercedes-Benz Strategic Partner, Q2 Revenue Forecast 850M-900M RMB

Baidu Qianfan Launches Token Welfare Package: Multi-Model Support with Prices Up to 50% Off

UOB Kay Hian Report Says Baidu Q1 Earnings Beat Expectations, Maintains Buy Rating with HKD 178 Target

CICC: Zai Labs Q1 Results In Line, Downgrades 2026-2027 Profit Forecasts and Target Prices

Amesite

InMed Pharmaceuticals

Meiwu Tech

Generation Income Properties

Co-Diagnostics

Phoenix Asia

MetaVia

Virax Biolabs

BAYVIEW ACQUISITION CORPORATION COM USD0.0001 (S/R) 17/11/2028

NextNRG

.HXC

China's April retail sales grew just 0.2%, the weakest since 2022, while industrial output rose 4.1%, missing forecasts. Fixed-asset investment contracted 1.6%, and domestic car sales fell 21.6% year-on-year. The National Bureau of Statistics described the international environment as grim, calling for proactive fiscal measures and accommodative monetary policy, but the Politburo offered no new stimulus. Analysts warn that the economy's 5.0% growth in Q1 may be hard to sustain amid rising energy costs from the Iran war and weak domestic demand.

- China's retail sales grew only 0.2% in April, marking the weakest performance since December 2022, while industrial output increased by just 4.1%, falling below expectations.  
- Fixed asset investment contracted by 1.6% in the first four months of 2026, reversing a prior growth trend, with domestic car sales down 21.6% for the seventh consecutive month.  
- The National Bureau of Statistics warned of a severe and complex international environment, urging for active fiscal measures and loose monetary policies, yet no new stimulus was announced, potentially disappointing the market.

Investinglive

China April data misses badly, Iran war and weak demand weigh. Retail sales growth plunge.

03896

BILI

09626

The Nasdaq China Golden Dragon Index experienced a 3% decline, reflecting a downturn in Chinese tech stocks. According to NS3.AI, Kingsoft Cloud saw a significant drop of 9.1%. Other major companies, including Bilibili, XPeng, and Baidu, also faced declines, each falling more than 5%.

CoinLive

KINGSOFT CLOUD

Kingsoft Cloud

Bilibili

BILIBILI-W

XPeng

XPENG-W

Baidu

BIDU-SW

BIDU-SWR

Nasdaq China Golden Dragon Index Declines 3% Amid Tech Stock Slump

.IXIC

.SPX

.DJI

A significant meeting between Chinese and U.S. Presidents is anticipated to enhance global stability. The summit aims to foster equal dialogue and cooperation amid international challenges. Recent interactions, including visits from U.S. officials and business leaders, indicate a positive shift in China-U.S. relations. The meeting is expected to strengthen bilateral ties and contribute to world peace.

MorningStar

NASDAQ Composite Index

S&P 500

Dow Jones Industrial Average

A Beijing Moment in a Changing World: A long-anticipated meeting between Chinese and US Leaders

MCHI

DRAG

China's factory-gate prices rose for the second consecutive month in April, with the producer price index (PPI) increasing by 2.8% year-on-year, surpassing economists' expectations of 1.7%. This rise follows a prolonged deflationary period. The consumer price index (CPI) also saw a year-on-year increase of 1.2%, driven by higher global oil prices and increased travel demand. Food prices fell by 1.6%, while non-food prices rose by 1.8%. Overall, the data indicates a shift in inflation trends in China amid ongoing geopolitical tensions.

Invesco Golden Dragon China

iShares MSCI China

Roundhill China Dragons ETF

China factory-gate prices rise for second straight month

China Foreign Minister Wang Yi announced that teams from China and the U.S. are finalizing trade outcomes. He encouraged dialogue between the U.S. and Iran and called for reopening the Strait of Hormuz. Both nations agreed to enhance trade and investment, addressing agricultural market access concerns. Xi is set to visit the U.S. in the fall, following an invitation from Trump.

China Foreign Minister:XI to visit the US in the Fall

YANG

China's April inflation data is expected today, following a surge in exports of 14.1% due to global stockpiling amid the Iran war. Analysts forecast the Consumer Price Index (CPI) to be around 0.8% to 1.0% year-on-year, slightly down from March's 1.0%. Core CPI is expected to remain between 1.1% and 1.2%, indicating weak domestic demand. The Producer Price Index (PPI) is projected to rise to 1.5% to 1.9% year-on-year, reflecting increased energy and commodity costs. The divergence between CPI and PPI will be crucial for market dynamics.

- In April, China’s export surged by 14.1% due to global stockpiling concerns stemming from the war in Iran.  
- Analysts predict that the Consumer Price Index (CPI) for April will be around 0.8% to 1.0%, reflecting a slight slowdown from March, while the Producer Price Index (PPI) is expected to rise between 1.5% and 1.9%, influenced by increasing energy and commodity costs.  
- The divergence between softening CPI and strengthening PPI will be a key focus for markets, highlighting the uneven nature of price recovery in China.

Direxion FTSE China Bear 3X

iShares China Large Cap

Economic and event calendar in Asia Monday, May 11, 2026 - China inflation data

KWEB

CQQQ

U.S. President Donald Trump has announced a trade agreement with China during a meeting with President Xi Jinping in Beijing. This announcement marks a significant step in U.S.-China trade relations and occurred on the final day of Trump's three-day state visit to China.

Krne Csi China Internet

Invesco China Tech

U.S. President Donald Trump Announces Trade Deal with China

399001

000001

U.S. President Donald Trump expressed optimism about the future of U.S.-China relations, stating they will become stronger than before. According to NS3.AI, Trump made this remark during his state visit to China.

Shenzhen Index

SSE Index

U.S.-China Relations Expected to Strengthen, Says Trump

President Trump is negotiating potential Chinese investments in the U.S., aiming to boost foreign investment, which he claims has reached nearly $20 trillion. However, skepticism exists in the U.S. regarding Chinese firms, with concerns over national security and job losses in manufacturing. Treasury Secretary Scott Bessent noted the creation of an investment board to guide acceptable Chinese investments. Despite a decline in Chinese investments due to stricter regulations, Trump seeks a significant deal, though challenges remain in overcoming political and regulatory barriers.

Businesstimes News

GOTION

NONGFU SPRING

Trump might welcome Chinese investment, but America is wary

China will grant up to two years of market exclusivity to manufacturers of eligible innovative pediatric drugs to boost R&D in pediatric medicines. The new policy, issued by the National Health Commission and other ministries, also introduces patent term compensations and aims to support the development of treatments for common childhood diseases and rare diseases. Regulators will assist in improving drug development efficiency and prioritize registration applications for innovative pediatric drugs. Additionally, the government will explore a national pediatric clinical trial network and support the development of commercial insurance products for children.

Yicai

China to Give Innovative Pediatric Drugmakers Market Exclusivity of Up to Two Years

NASDAQ Golden Dragon China Index(.HXC.US)